Schedule 13G ownership disclosure
ESSA PHARMA INC
Security class unavailable · CUSIP: 29668H104
Event date: 2016-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,696,968
- Percent of class
- 9.9900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001535264-17-000034
- Form type
- SC 13G
- Filer
- ESSA Pharma Inc.
- CIK
- CIK 1633932
- Filed
- Feb 10, 2017
- Reporting period
- Dec 31, 2016
- Description
- Schedule 13G beneficial ownership